# Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy

> **NCT02582333** · — · COMPLETED · sponsor: **Taichung Veterans General Hospital** · enrollment: 347 (actual)

## Conditions studied

- Virological Breakthrough
- Prognosis

## Interventions

- **OTHER:** Observation for clinical and virological changes

## Key facts

- **NCT ID:** NCT02582333
- **Lead sponsor:** Taichung Veterans General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2021-03-13
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582333, "Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*